The New Jersey Legislature last year finally jump-started its medicinal cannabis program after nearly a decade of over-regulation-induced dysfunction. The Compassionate Use of Medical Cannabis Act (CUMCA) Jake’s Law was passed in July, promising patients expanded access to cannabis, with a variety of cannabis products and at a more reasonable, affordable price. But so far only one new alternative treatment center has opened and prices are still the highest in the country.
Senate President Steve Sweeney’s plan to make medical cannabis affordable is through industry expansion. While that plan will already take years (that patients don’t have) to achieve, it may be even longer with new court-imposed delays on alternative treatment center (ATC) licensing.
With continued delays and lack of access, many patients will suffer and die before there’s a meaningful reduction in the legal market price.
Patients can no longer afford to wait and shouldn’t have to bear the financial burden of corporate cannabis expansion when we’re talking about a plant many can grow themselves. Home-cultivated cannabis is roughly a quarter of the price of current ATC cannabis.